Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | LCK | P06239 | 1/20 | 0.37 |
| ▸ | FYN | P06241 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL890395 | 0.95 | LCK (0.41) | ALDH1A1HSD17B10TDP1LCKFYN | |
| SCHEMBL5278000 | 0.87 | TPMT (0.40) | ALDH1A1HSD17B10TDP1LCKFYN | |
| SCHEMBL11886838 | 0.86 | TPMT (0.39) | ALDH1A1HSD17B10TDP1LCKFYN | |
| SCHEMBL2003193 | 0.86 | CES2 (0.40) | ALDH1A1HSD17B10TDP1LCKFYN | |
| SCHEMBL15870330 | 0.81 | FLT1 (0.31) | ALDH1A1TSHR | |
| SCHEMBL11668400 | 0.81 | LCK (0.58) | ALDH1A1HSD17B10TDP1LCKFYN | |
| SCHEMBL8747785 | 0.81 | LCK (0.58) | ALDH1A1HSD17B10TDP1LCKFYN | |
| SCHEMBL2568764 | 0.79 | LMNA (0.40) | ALDH1A1HSD17B10LCKFYN | |
| SCHEMBL218559 | 0.79 | ALDH1A1 (0.53) | ALDH1A1HSD17B10TDP1 | |
| SCHEMBL30525020 | 0.79 | ALDH1A1 (0.46) | ALDH1A1HSD17B10TDP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108069853-B | Synthetic method of 3, 5-dichlorobenzoyl chloride | 江西吉翔医药化工有限公司 | 2020-12-22 | — | — | CN | disclosed |
| EP-2858740-B1 | METHOD FOR MAKING MEMBRANE COMPOSITE POLYAMIDE MEMBRANE WITH COMBINATION OF DIFFERENT POLYFUNCTIONAL AMINE-REACTIVE MONOMERS | DDP SPECIALITY ELECTRONIC MAT US INC (US) | 2020-03-25 | — | — | EP | disclosed |
| US-9925500-B2 | Membrane derived from polyfunctional amine and combination of different polyfunctional amine-reactive monomers | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-03-27 | — | — | US | disclosed |
| US-9630149-B2 | Composite polyamide membrane with improved structure | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-04-25 | — | — | US | disclosed |
| US-9610542-B2 | Composite polyamide membrane with increased carboxylic acid functionality | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-04-04 | — | — | US | disclosed |
| CN-106349121-A | Preparation method of 3,5-dichlorobenzoyl chloride | 上海绿麟达新材料科技有限公司 | 2017-01-25 | — | — | CN | disclosed |
| US-20150174534-A1 | MEMBRANE DERIVED FROM POLYFUNCTIONAL AMINE AND COMBINATION OF DIFFERENT POLYFUNCTIONAL AMINE-REACTIVE MONOMERS | DOW GLOBAL TECHNOLOGIES LLC | 2015-06-25 | — | — | US | disclosed |
| US-20150165387-A1 | COMPOSITE POLYAMIDE MEMBRANE WITH IMPROVED STRUCTURE | THE DOW CHEMICAL COMPANY | 2015-06-18 | — | — | US | disclosed |
| EP-2874733-A1 | COMPOSITE POLYAMIDE MEMBRANE WITH INCREASED CARBOXYLIC ACID FUNCTIONALITY | Dow Global Technologies LLC (US) | 2015-05-27 | — | — | EP | disclosed |
| US-20150129485-A1 | COMPOSITE POLYAMIDE MEMBRANE WITH INCREASED CARBOXYLIC ACID FUNCTIONALITY | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-05-14 | — | — | US | disclosed |
| US-7456195-B2 | Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-11-25 | — | — | US | disclosed |
| EP-1910298-A2 | PHENYLGLYCINAMIDE AND PYRIDYLGLYCINAMIDE DERIVATIVES USEFUL AS ANTICOAGULANTS | Brystol-Myers Squibb Company (US) | 2008-04-16 | — | — | EP | disclosed |
| WO-2007002313-A2 | PHENYLGLYCINAMIDE AND PYRIDYLGLYCINAMIDE DERIVATIVES USEFUL AS ANTICOAGULANTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-01-04 | — | — | WO | disclosed |
| US-20070003539-A1 | Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-01-04 | — | — | US | disclosed |
| WO-2001010838-A1 | MULTIVALENT COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 2001-02-15 | — | — | WO | disclosed |
| EP-0144810-B1 | CURABLE COMPOSITION | PPG INDUSTRIES, INC. (US) | 1989-08-23 | — | — | EP | disclosed |
| EP-0144810-A2 | Curable composition | PPG INDUSTRIES, INC. (US) | 1985-06-19 | — | — | EP | disclosed |
| EP-0142805-A2 | Aminoplast curable compositions containing disulfonic acid esters as latent acid catalysts | PPG INDUSTRIES, INC. (US) | 1985-05-29 | — | — | EP | disclosed |
| US-4501854-A | FILMS, COATINGS, PAINTS, MOLDINGS, LAMINATES | PPG INDUSTRIES, INC. (US) | 1985-02-26 | — | — | US | disclosed |
| US-4500680-A | BENZENESULFONIC ACIDS | PPG INDUSTRIES, INC. (US) | 1985-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070003539-A1 | Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants | F12, F11, F7 | ALDH1A1 2963/4885HSD17B10 4277/4885TDP1 799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.